These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31486315)

  • 1. [(S)un (M)ay (A)rise on SMA : the hope of a region without spinal muscular atrophy].
    Boemer F; Caberg JH; Dideberg V; Beckers P; Marie S; Marcelis L; Bours V; Dangouloff T; Servais L
    Rev Med Liege; 2019 Sep; 74(9):461-464. PubMed ID: 31486315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium.
    Boemer F; Caberg JH; Beckers P; Dideberg V; di Fiore S; Bours V; Marie S; Dewulf J; Marcelis L; Deconinck N; Daron A; Blasco-Perez L; Tizzano E; Hiligsmann M; Lombet J; Pereira T; Lopez-Granados L; Shalchian-Tehran S; van Assche V; Willems A; Huybrechts S; Mast B; van Olden R; Dangouloff T; Servais L
    Sci Rep; 2021 Oct; 11(1):19922. PubMed ID: 34620959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for SMA in Southern Belgium.
    Boemer F; Caberg JH; Dideberg V; Dardenne D; Bours V; Hiligsmann M; Dangouloff T; Servais L
    Neuromuscul Disord; 2019 May; 29(5):343-349. PubMed ID: 31030938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.
    Dangouloff T; Vrščaj E; Servais L; Osredkar D;
    Neuromuscul Disord; 2021 Jun; 31(6):574-582. PubMed ID: 33985857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond.
    Groulx-Boivin E; Osman H; Chakraborty P; Lintern S; Oskoui M; Selby K; Van Caeseele P; Wyatt A; McMillan HJ
    Can J Neurol Sci; 2024 Mar; 51(2):203-209. PubMed ID: 36892082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme.
    D'Silva AM; Kariyawasam DST; Best S; Wiley V; Farrar MA;
    Dev Med Child Neurol; 2022 May; 64(5):625-632. PubMed ID: 34839535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
    Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C
    Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis.
    Shih ST; Farrar MA; Wiley V; Chambers G
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1296-1304. PubMed ID: 34321343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
    Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
    Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.